City of Hope
For the millions of people living with cancer, medical research provides hope. For nearly a century, City of Hope (COH) has been committed to saving lives. City of Hope researchers speed their findings from the lab to clinical trials, because patients urgently need better treatments for cancer and other serious diseases. At the same time, City of Hope is deeply committed to delivering compassionate care that treats the whole person, not just the disease.
City of Hope is one of only 40 National Cancer Institute-designated Comprehensive Cancer Centers in the United States and a founding member of the National Comprehensive Cancer Network, an alliance of 20 top centers that recommends national guidelines for treatment. U.S. News and World Report named City of Hope one of "America’s Best Hospitals" in cancer and urology.
Scientists at City of Hope have contributed significantly to the world of medicine and the well-being of patients throughout the country. City of Hope research gave rise to synthetic human insulin and targeted cancer-fighting drugs such as Herceptin, Rituxin and Avastin. It also pioneered the technology of bone marrow transplantation and continues to contribute much-needed progress in the fight against HIV and diabetes. ThinkCure! supports lymphoma research at City of Hope, which is also federally funded by the Specialized Program of Research Excellence (SPORE) grant. City of Hope experts collaborate with others throughout the world and train the next generation of scientists so their lifesaving legacy reaches even farther.
Donate now to promote this legacy and help us continue our work with City of Hope to find cures for cancer.